Literature DB >> 17511913

Colitis-associated cancer and dysplasia surveillance: an opposing perspective.

Fergus Shanahan1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17511913     DOI： 10.1007/s11894-007-0014-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  10 in total

Review 1.  Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.

Authors:  P D Collins; C Mpofu; A J Watson; J M Rhodes
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

3.  Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.

Authors:  Ralf Kiesslich; Johannes Fritsch; Martin Holtmann; Heinz H Koehler; Manfred Stolte; Stephan Kanzler; Bernhard Nafe; Michael Jung; Peter R Galle; Markus F Neurath
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

4.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.

Authors:  Tine Jess; Edward V Loftus; Fernando S Velayos; W Scott Harmsen; Alan R Zinsmeister; Thomas C Smyrk; Cathy D Schleck; William J Tremaine; L Joseph Melton; Pia Munkholm; William J Sandborn
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.

Authors:  Matthew D Rutter; Brian P Saunders; Kay H Wilkinson; Steve Rumbles; Gillian Schofield; Michael A Kamm; Christopher B Williams; Ashley B Price; Ian C Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

Authors:  Charles N Bernstein; James F Blanchard; Colleen Metge; Marina Yogendran
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

7.  Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.

Authors:  C N Bernstein; W M Weinstein; D S Levine; F Shanahan
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

8.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

Authors:  C E Rubin; R C Haggitt; G C Burmer; T A Brentnall; A C Stevens; D S Levine; P J Dean; M Kimmey; D R Perera; P S Rabinovitch
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

Review 9.  Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease.

Authors:  J Eaden
Journal:  Aliment Pharmacol Ther       Date:  2003-09       Impact factor: 8.171

Review 10.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

Authors:  C N Bernstein; F Shanahan; W M Weinstein
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.